JP2004532301A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004532301A5 JP2004532301A5 JP2002574989A JP2002574989A JP2004532301A5 JP 2004532301 A5 JP2004532301 A5 JP 2004532301A5 JP 2002574989 A JP2002574989 A JP 2002574989A JP 2002574989 A JP2002574989 A JP 2002574989A JP 2004532301 A5 JP2004532301 A5 JP 2004532301A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- substituted
- residue
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 21
- 125000006716 (C1-C6) heteroalkyl group Chemical group 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 229910052760 oxygen Inorganic materials 0.000 claims 7
- 229910052717 sulfur Inorganic materials 0.000 claims 7
- 125000003277 amino group Chemical group 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims 4
- 125000004405 heteroalkoxy group Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 4
- 229920000642 polymer Polymers 0.000 claims 4
- 125000000547 substituted alkyl group Chemical group 0.000 claims 4
- 125000003107 substituted aryl group Chemical group 0.000 claims 4
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 4
- -1 N-hydroxybenzotriazolyl Chemical group 0.000 claims 3
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 claims 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 238000006116 polymerization reaction Methods 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 claims 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 claims 1
- 241000219198 Brassica Species 0.000 claims 1
- 235000003351 Brassica cretica Nutrition 0.000 claims 1
- 235000003343 Brassica rupestris Nutrition 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 229930012538 Paclitaxel Natural products 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000003213 activating effect Effects 0.000 claims 1
- 229940045799 anthracyclines and related substance Drugs 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 claims 1
- 229960000975 daunorubicin Drugs 0.000 claims 1
- 229960004679 doxorubicin Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 1
- 229960005277 gemcitabine Drugs 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 235000010460 mustard Nutrition 0.000 claims 1
- 229960001592 paclitaxel Drugs 0.000 claims 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
- 150000004579 taxol derivatives Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27829801P | 2001-03-23 | 2001-03-23 | |
| PCT/US2002/008664 WO2002076476A2 (en) | 2001-03-23 | 2002-03-21 | Prodrugs of anticancer agents employing substituted aromatic acids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004532301A JP2004532301A (ja) | 2004-10-21 |
| JP2004532301A5 true JP2004532301A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
| JP4267326B2 JP4267326B2 (ja) | 2009-05-27 |
Family
ID=23064458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002574989A Expired - Fee Related JP4267326B2 (ja) | 2001-03-23 | 2002-03-21 | 置換芳香族酸を用いる抗癌剤プロドラッグ |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6936597B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1379257B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4267326B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE439147T1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2440091C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60233315D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1379257T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2331562T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03008192A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002076476A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6624142B2 (en) * | 1997-12-30 | 2003-09-23 | Enzon, Inc. | Trimethyl lock based tetrapartate prodrugs |
| DE602004027000D1 (de) * | 2003-01-17 | 2010-06-17 | Advanced Proteome Therapeutics | Verfahren zur Identifizierung aktivierter Polymer-Komplexe zur sekundären Stellen-spezifischen Modifikation von Protein Ziel-Gruppen. |
| US7332164B2 (en) * | 2003-03-21 | 2008-02-19 | Enzon Pharmaceuticals, Inc. | Heterobifunctional polymeric bioconjugates |
| CZ294996B6 (cs) * | 2003-07-16 | 2005-04-13 | Ústav Makromolekulární Chemie Av Čr | Reaktivní polymery a kopolymery na bázi N-(2-hydroxypropyl)methakrylamidu, způsob jejich přípravy a jejich použití pro syntézu polymerních léčiv, pro modifikaci biologicky aktivních proteinů a přípravu systémů pro dopravu genů |
| JP4723380B2 (ja) * | 2003-09-25 | 2011-07-13 | テルモ株式会社 | ポリエチレングリコール誘導体及びこれを膜構成成分とする薬物担体 |
| JP2007514699A (ja) * | 2003-12-19 | 2007-06-07 | ノバルティス アクチエンゲゼルシャフト | （ａ）Ｎ−｛５−［４−（４−メチル−ピペラジノ−メチル）−ベンゾイルアミド］−２−メチルフェニル｝−４−（３−ピリジル）−２−ピリミジン−アミンおよび（ｂ）少なくとも１個のハイプシン化阻害剤を含む組み合わせ物およびその使用 |
| US7282590B2 (en) * | 2004-02-12 | 2007-10-16 | The Research Foundation Of State University Of New York | Drug conjugates |
| TW200922623A (en) * | 2007-07-11 | 2009-06-01 | Enzon Pharmaceuticals Inc | Polymeric drug delivery systems containing an aromatic allylic acid |
| JP2010533202A (ja) * | 2007-07-11 | 2010-10-21 | エンゾン ファーマシューティカルズ，インコーポレーテッド | 多置換芳香族部分を含むポリマー性薬剤送達システム |
| US8741858B2 (en) | 2007-09-21 | 2014-06-03 | Zhongxu Ren | Oligomer-nucleoside phosphate conjugates |
| EP3820879B1 (en) | 2018-06-29 | 2024-11-06 | Changchun Changcheng Pharmaceutical Technology Co., LTD | Phosphorus-containing prodrugs of gemcitabine |
| US11364711B2 (en) | 2018-12-21 | 2022-06-21 | The Clorox Company | Multi-layer substrates comprising sandwich layers and polyethylene |
| WO2020205360A1 (en) | 2019-04-02 | 2020-10-08 | The Clorox Company | Process for manufacturing multi-layer substrates comprising sandwich layers and polyethylene |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684728A (en) * | 1979-01-12 | 1987-08-04 | Bayer Aktiengesellschaft | Solubilizing biologically active compounds with reactive hydrogen atoms |
| GB8430253D0 (en) * | 1984-11-30 | 1985-01-09 | Beecham Group Plc | Compounds |
| US6610841B1 (en) | 1997-12-18 | 2003-08-26 | Gilead Sciences, Inc. | Nucleotide-based prodrugs |
| US5482719A (en) * | 1992-10-30 | 1996-01-09 | Guillet; James E. | Drug delivery systems |
| AU6486494A (en) * | 1993-06-24 | 1995-01-05 | Siemens Aktiengesellschaft | Compound and method of applying anti-fouling coatings on medical devices |
| US5919455A (en) * | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5605976A (en) | 1995-05-15 | 1997-02-25 | Enzon, Inc. | Method of preparing polyalkylene oxide carboxylic acids |
| JP4038600B2 (ja) * | 1997-06-02 | 2008-01-30 | 日油株式会社 | ヒドロキシアルキルフェノン誘導体及びその用途 |
| US6180095B1 (en) * | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| US5965119A (en) | 1997-12-30 | 1999-10-12 | Enzon, Inc. | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| JP2000056428A (ja) * | 1998-08-12 | 2000-02-25 | Konica Corp | 熱現像写真感光材料 |
| JP3485023B2 (ja) * | 1999-05-20 | 2004-01-13 | 東亞合成株式会社 | ヌクレオシド化合物 |
| JP3485024B2 (ja) * | 1999-05-20 | 2004-01-13 | 東亞合成株式会社 | ヌクレオチド化合物 |
| WO2001017501A1 (en) * | 1999-09-10 | 2001-03-15 | The Procter & Gamble Company | Enzyme inhibitors |
-
2002
- 2002-03-21 WO PCT/US2002/008664 patent/WO2002076476A2/en not_active Ceased
- 2002-03-21 EP EP02717687A patent/EP1379257B1/en not_active Expired - Lifetime
- 2002-03-21 DK DK02717687T patent/DK1379257T3/da active
- 2002-03-21 DE DE60233315T patent/DE60233315D1/de not_active Expired - Lifetime
- 2002-03-21 US US10/103,323 patent/US6936597B2/en not_active Expired - Fee Related
- 2002-03-21 ES ES02717687T patent/ES2331562T3/es not_active Expired - Lifetime
- 2002-03-21 CA CA2440091A patent/CA2440091C/en not_active Expired - Fee Related
- 2002-03-21 MX MXPA03008192A patent/MXPA03008192A/es active IP Right Grant
- 2002-03-21 JP JP2002574989A patent/JP4267326B2/ja not_active Expired - Fee Related
- 2002-03-21 AT AT02717687T patent/ATE439147T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004532301A5 (cg-RX-API-DMAC7.html) | ||
| JP2004532289A5 (cg-RX-API-DMAC7.html) | ||
| CA2824093C (en) | Polymeric prodrug with a self-immolative linker | |
| WO2011162252A1 (ja) | 分岐型ヘテロポリエチレングリコールおよび中間体 | |
| KR100608415B1 (ko) | 폴리알킬렌 글리콜산 첨가제 | |
| EA200000607A1 (ru) | Конъюгаты эритропоэтина | |
| JP2005520006A5 (cg-RX-API-DMAC7.html) | ||
| JP2006505634A5 (cg-RX-API-DMAC7.html) | ||
| JP2014501765A5 (cg-RX-API-DMAC7.html) | ||
| CA2312975A1 (en) | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents | |
| KR20140024833A (ko) | 신규한 시티딘계 대사길항제의 고분자 유도체 | |
| CN101534861B (zh) | 具有基于位阻酯的生物可降解连接基的聚环氧烷 | |
| JP2004530736A5 (cg-RX-API-DMAC7.html) | ||
| JP2014503548A5 (cg-RX-API-DMAC7.html) | ||
| JP2002520288A5 (cg-RX-API-DMAC7.html) | ||
| KR101041985B1 (ko) | 핵산 전달용 고분자의 제조방법 및 상기 고분자를 함유하는 핵산 전달용 조성물 | |
| CA2440091A1 (en) | Prodrugs of anticancer agents employing substituted aromatic acids | |
| WO2008131325A2 (en) | Macromonomers and hydrogel systems using native chemical ligation, and their methods of preparation | |
| EP3950703A1 (en) | Branched degradable polyethylene glycol binder | |
| WO1999057174A1 (en) | Polyoxyethylene derivatives having optionally protected amino group at one end and process for producing the same | |
| WO2001010934A1 (en) | Block copolymer having polymer segment derived from oxazoline | |
| EP1625855A1 (en) | Polymeric prodrug with a self-immolative linker | |
| EP3778705B1 (en) | Degradable polyethylene glycol derivative | |
| EP4035678B1 (en) | Degradable multi-arm polyethylene glycol derivative | |
| Alsehli et al. | Dendritic polymer micelles for drug delivery |